Prospective evaluation of a follow-up schedule in cutaneous melanoma patients:: Recommendations for an effective follow-up strategy

被引:194
|
作者
Garbe, C
Paul, A
Kohler-Späth, H
Ellwanger, U
Stroebel, W
Schwarz, M
Schlagenhauff, B
Meier, F
Schittek, B
Blaheta, HJ
Blum, A
Rassner, G
机构
[1] Univ Tubingen, Dept Dermatol, Skin Cancer Program, D-72076 Tubingen, Germany
[2] German Soc Dermatol, Cent Malignant Melanoma Registry, Tubingen, Germany
关键词
D O I
10.1200/JCO.2003.01.091
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose : To prospectively examine and evaluate the results of follow-up procedures in a large cohort of cutaneous melanoma patients. Patients and Methods: This was a prospective study in 2,008 consecutive patients with stage I to IV cutaneous melanoma from 1996 to 1998 on the yield of stage-appropriate follow-up examinations according to the German guidelines. Documentation of patient and follow-up data comprised patient demography, primary tumor specifics, and any clinical and technical examinations performed. The detection of metastasis was classified as early or late, and the means of their detection and the resulting overall survival probabilities were examined. Results: A total of 3,800 clinical examinations and 12,398 imaging techniques were documented. Sixty-two second primary melanomas in 46 patients and 233 disease recurrences in 112 patients were detected during this time. In stage I to III disease, physical examination was responsible for the discovery of 50% of all recurrences. In the primary tumor stages, 21% of all recurrences were discovered by lymph node sonography, with the majority being classified as early detection. Forty-eight percent of the recurrences were classified as early detection, and these patients had a significant benefit of overall survival probability. Conclusion: The results of our study suggest that an elaborated follow-up schedule in cutaneous melanoma is suitable for the early detection of second primary melanomas and early recurrences. The intensity of clinical and technical examinations can be reduced during follow-up of patients in the primary tumor stages and may be intensified in locoregional disease. Recommendations for an effective follow-up strategy are outlined. (C) 2003 by American Society of Clinical Oncology.
引用
收藏
页码:520 / 529
页数:10
相关论文
共 50 条
  • [31] Management of melanoma patients: Benefit of intense follow-up schedule is not demonstrated - Reply
    Garbe, C
    Leiter, U
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (19) : 3707 - 3708
  • [32] Prospective evaluation of follow-up in melanoma patients in Germany - Results of a multicentre and longitudinal study
    Livingstone, E.
    Krajewski, C.
    Eigentler, T. K.
    Windemuth-Kieselbach, C.
    Benson, S.
    Elsenbruch, S.
    Hauschild, A.
    Rompel, R.
    Meiss, F.
    Mauerer, A.
    Kaehler, K. C.
    Dippel, E.
    Moellenhoff, K.
    Kilian, K.
    Mohr, P.
    Utikal, J.
    Schadendorf, D.
    [J]. EUROPEAN JOURNAL OF CANCER, 2015, 51 (05) : 653 - 667
  • [33] Recurrence of thin melanoma: How effective is follow-up?
    Moloney, DM
    Gordon, DJ
    Briggs, JC
    Rigby, HS
    [J]. BRITISH JOURNAL OF PLASTIC SURGERY, 1996, 49 (06): : 409 - 413
  • [34] ESMO Minimum Clinical Recommendations for diagnosis, treatment and follow-up of cutaneous malignant melanoma
    Jost, LM
    Jelic, S
    Purkalne, G
    [J]. ANNALS OF ONCOLOGY, 2005, 16 : 66 - 68
  • [35] ESMO Minimum Clinical Recommendations for diagnosis, treatment and follow-up of cutaneous malignant melanoma
    Jost, LM
    [J]. ANNALS OF ONCOLOGY, 2003, 14 (07) : 1012 - 1013
  • [36] A rational approach to the follow-up of melanoma patients
    Garbe, C
    [J]. CANCERS OF THE SKIN, PROCEEDINGS, 2002, 160 : 205 - 215
  • [37] Follow-up of early stage melanoma: Specialist clinician perspectives on the functions of follow-up and implications for extending follow-up intervals
    Rychetnik, Lucie
    McCaffery, Kirsten
    Morton, Rachael L.
    Thompson, John F.
    Menzies, Scott W.
    Irwig, Les
    [J]. JOURNAL OF SURGICAL ONCOLOGY, 2013, 107 (05) : 463 - 468
  • [38] What is the "Optimal" follow-up schedule for ICD patients?
    Senges-Becker, JC
    Klostermann, M
    Becker, R
    Bauer, A
    Siegler, KE
    Katus, HA
    Schoels, W
    [J]. EUROPACE, 2005, 7 (04): : 319 - 326
  • [39] What is the "optimal" follow-up schedule for ICD patients?
    Senges-Becker, JC
    Klostermann, M
    Becker, R
    Weretka, S
    Siegler, KE
    Schoels, W
    [J]. CIRCULATION, 2003, 108 (17) : 616 - 616
  • [40] Effective Radiation Exposure in Evaluation and Follow-up of Patients With Urolithiasis
    Fahmy, Nader M.
    Elkoushy, Mohamed A.
    Andonian, Sero
    [J]. UROLOGY, 2012, 79 (01) : 43 - 47